Longevity is being framed as a consumer movement when, in reality, it is a pharmaceutical pipeline challenge. And pharma isn’t treating it like one yet. In recent years, longevity has become a ...

Schwab U.S. Dividend Equity ETF now overweights energy, consumer defensive, and healthcare. Find out why SCHD is a Buy.

Frontdoor, Inc. is rated a Buy due to strong FCF, robust return on capital, and undervalued EV/EBIT multiples. Learn more ...